KELLER WILLIAM R 4
4 · ALEXION PHARMACEUTICALS INC · Filed Feb 6, 2012
Insider Transaction Report
Form 4
KELLER WILLIAM R
Director
Transactions
- Exercise/Conversion
Common Stock, par value $.0001 per share
2012-02-03+3,115→ 9,805 total
Footnotes (1)
- [F1]Award of Restricted Stock Units pursuant to the 2004 Incentive Plan. 100% vests one year from date of grant.